Jean-Luc Belingard News
Most Popular Jean-Luc Belingard Story
Ipsen execs juggling 'too many' pipeline projects
Ipsen CEO Jean-Luc Belingard is plagued by the abundance of promising drugs in his pipeline. "We have enough products in early development, we may even have too many," he tells Bloomberg in an Read more...
Latest Headlines
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
